Abstracts ASN Report 2019
results. The radiation protection organisation of these facilities is satisfactory and staff are familiar with the regulations. National action plans have been put into place by the licensees and are monitored by ASN in order to ensure continuous improvement of radiation protection and safety in these facilities. Three significant events concerning radiation protection were ŅĸŃłŅŇĸķ ļŁ ӅӃӄӌє łŁĸ łĹ ŇĻĸņĸ ĸʼnĸŁŇņ Ŀĸķ Ňł ņļĺŁļĹļĶĴŁŇ ĸŋŃłņňŅĸ łĹ ŊłŅľĸŅņ łŅ ŇĻĸ ŃňĵĿļĶє Łĸ ĸʼnĸŁŇ ŊĴņ ŅĴŇĸķ ĿĸʼnĸĿ ӄׇłŁ ŇĻĸ INES scale due to exceeding of the gaseous discharge limits set out in the license. Corrective measures were implemented by the licensee, including a system for continuous monitoring of discharges, allowing the immediate detection of any drift in gaseous effluent discharges. There are disparities in the technical and organisational means implemented by the licensees, depending on the age of the facilities and the type of activities performed (research or industrial production). Experience feedback in this area has led ASN, assisted by IRSN, to draw up a draft regulatory text on the technical design and operating rules applicable to companies producing radionuclides using a cyclotron. This draft text was made available for consultation by the stakeholders in 2016. A Ņĸʼnļņĸķ ʼnĸŅņļłŁ ŊĴņ ŃŅłķňĶĸķ ļŁ ӅӃӄӋё ŇĴľļŁĺ ĴĶĶłňŁŇ łĹ ŇĻĸ observations received and including additional chapters on the control and monitoring of gaseous effluent discharges. This second version of this draft underwent a new consultation by ŇĻĸ ņŇĴľĸĻłĿķĸŅņ ļŁ ӅӃӄӌє Ļĸ ļŁŇĸŅļŀ ĶłŁĶĿňņļłŁņ ĴŅĸ ŁĸʼnĸŅŇĻĸĿĸņņ already used when reviewing license application and defining licence conditions. Discussions with IRSN and the DGT will ĶłŁŇļŁňĸ ļŁ ӅӃӅӃׇļŁ łŅķĸŅ Ňł ĹļŁĴĿļņĸ ŇĻļņ ķŅĴĹŇ ŇĸŋŇ ĴŁķ ĻĴʼnĸ a single regulatory baseline for the entire sector of activity concerned. ג ِ ב Áǝƺ ȒɎǝƺȸ ɀɖȵȵǼǣƺȸɀ Ȓǔ ɀȒɖȸƬƺɀ • 0ɮƏǼɖƏɎǣȒȇ Ȓǔ ȸƏƳǣƏɎǣȒȇ ȵȸȒɎƺƬɎǣȒȇ Suppliers of radioactive sources, cyclotrons excluded, propose technical solutions for the industrial, medical and research sectors. Suppliers may be manufacturers of “bare” sources or of devices containing sealed radioactive sources, manufacturers of unsealed sources, or distributors who import sources from other countries. Whatever the case, ASN examines the license applications submitted by these suppliers for the sources they ļŁŇĸŁķ Ňł ķļņŇŅļĵňŇĸ ļŁ ŅĴŁĶĸє Ł ӅӃӄӌё ӅӋׇļŁņŃĸĶŇļłŁņ łĹ ņňŃŃĿļĸŅņ łĹ ņłňŅĶĸņ łŇĻĸŅ ŇĻĴŁ cyclotrons were conducted at manufacturers/distributors of sealed and unsealed sources, companies involved in the dismantling and reconditioning of ICSDs, companies recovering lightning conductors and companies manufacturing and installing X-ray generators (although they do not yet have a distribution license, the utilisation of these devices is regulated, including the commissioning and maintenance operations carried out by the companies that sell them). Some of these inspections focused on ĹłŅĸļĺŁ ĶłŀŃĴŁļĸņ ņňŃŃĿŌļŁĺ ŃŅłķňĶŇņ ļŁ ŅĴŁĶĸє These inspections have covered about a third of the suppliers with safety-significant business, with specific inspection indicators directed at their responsibilities as source suppliers for the tracking and recovery of disused sealed sources to dispose of them appropriately considering the radiation risks they present for people and the environment. ASN considers the radiation protection situation associated with the radionuclide distribution activity to be satisfactory on the whole. The large majority of licensees meet the main requirements and assume their responsibilities adequately (verifications prior to supply, technical verifications of the supplied sources, setting up the source recovery streams, transmission of information to IRSN). These inspections also served to inform source suppliers LA RÉUNION GUADELOUPE Joint use Research Production for medical applications On standby Planned Location of cyclotrons in France ASN Report on the state of nuclear safety and radiation protection in France in 2019 253 ٲ ז SOURCES OF IONISING RADIATION AND THEIR INDUSTRIAL, VETERINARY AND RESEARCH APPLICATIONS 08
RkJQdWJsaXNoZXIy NjQ0NzU=